DHI
48
4
AIV
72
2
BAC
53
3
LEG
36
4
PLD
56
8
SEE
56
6
EQT
57
-2
AXP
71
2
TDC
80
4
CL
58
2
MLM
57
6
NAVI
52
5
DTE
56
2
PSA
58
2
URI
65
5
CVX
47
3
HP
48
3
RIG
60
2
SIG
52
3
XRX
44
3
DHI
48
4
AIV
72
2
BAC
53
3
LEG
36
4
PLD
56
8
SEE
56
6
EQT
57
-2
AXP
71
2
TDC
80
4
CL
58
2
MLM
57
6
NAVI
52
5
DTE
56
2
PSA
58
2
URI
65
5
CVX
47
3
HP
48
3
RIG
60
2
SIG
52
3
XRX
44
3
Financhill
Back

Precision BioSciences Vs. Protagonist Therapeutics Industry Stock Comparison

Sell
10

DTIL
Precision BioSciences

Last Price:
7.21
Seasonality Move:
-17.66%
Sell
45

PTGX
Protagonist Therapeutics

Last Price:
46.45
Seasonality Move:
11.46%
Sell
10
Precision BioSciences (DTIL) is a Sell

Is Precision BioSciences a Buy, Sell or Hold?

  • The current Precision BioSciences [DTIL] share price is $7.26. The Score for DTIL is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • DTIL is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $46.46. The Score for PTGX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DTIL Stock Price Chart

What is Precision BioSciences's stock price today?

  • The Precision BioSciences share price today is $7.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DTIL is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $46.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.

DTIL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.48 Sell
Relative Strength Index (14 RSI): 37.48 Sell
Chaikin Money Flow: 62334 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.5 - 8.72) Sell
Bollinger Bands (100): (8.33 - 10.03) Sell

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.01 Sell
Relative Strength Index (14 RSI): 57.05 Buy
Chaikin Money Flow: 782176 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.22 - 47.9) Buy
Bollinger Bands (100): (38.27 - 46.31) Buy

DTIL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.35 Sell
20-day SMA: 7.99 Sell
50-day SMA: 8.7 Sell
200-day SMA: 10.61 Sell
8-day EMA: 7.34 Sell
20-day EMA: 7.85 Sell
50-day EMA: 8.52 Sell
200-day EMA: 10.87 Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.58 Buy
20-day SMA: 44.66 Buy
50-day SMA: 45.25 Buy
200-day SMA: 35.78 Buy
8-day EMA: 42.72 Buy
20-day EMA: 43.78 Buy
50-day EMA: 44.02 Buy
200-day EMA: 36.88 Buy

Precision BioSciences Earnings Growth & DTIL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $20.23 per share, and a decrease next year of $9.65 per share.

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.

Precision BioSciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):